Mercator Medical S.A. (WSE:MRC)
Poland
· Delayed Price · Currency is PLN 43.15
-0.05 (-0.12%)
May 21, 2025, 10:33 AM CET
Mercator Medical Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 542.49 | 469.06 | 542.51 | 1,727 | 1,834 | Upgrade
|
| Other Revenue | 71.26 | 0.16 | 0.25 | 1.86 | 1.21 | Upgrade
|
| Revenue | 613.75 | 469.23 | 542.77 | 1,729 | 1,835 | Upgrade
|
| Revenue Growth (YoY) | 30.80% | -13.55% | -68.61% | -5.79% | 240.06% | Upgrade
|
| Cost of Revenue | 406.79 | 378.18 | 445.94 | 1,084 | 645.87 | Upgrade
|
| Gross Profit | 206.96 | 91.05 | 96.82 | 644.96 | 1,190 | Upgrade
|
| Selling, General & Admin | 132.78 | 126.7 | 144.94 | 147.73 | 116.92 | Upgrade
|
| Other Operating Expenses | 19.78 | 15.91 | 0.97 | 14.96 | 6.91 | Upgrade
|
| Operating Expenses | 175.86 | 164.72 | 171.57 | 182 | 142.35 | Upgrade
|
| Operating Income | 31.1 | -73.68 | -74.75 | 462.96 | 1,047 | Upgrade
|
| Interest Expense | -14.35 | -0.83 | -0.33 | -0.12 | -3.95 | Upgrade
|
| Interest & Investment Income | - | 23.68 | 14.06 | 0.84 | 0.74 | Upgrade
|
| Earnings From Equity Investments | - | - | - | 2.28 | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | -17.22 | 19.02 | -2.9 | Upgrade
|
| Other Non Operating Income (Expenses) | 25.11 | 61.96 | 24.21 | -1.12 | 1.04 | Upgrade
|
| EBT Excluding Unusual Items | 41.86 | 11.13 | -54.03 | 483.86 | 1,042 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -4.93 | -6.38 | -0.13 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 0.5 | 0.47 | 0.1 | -1.26 | Upgrade
|
| Asset Writedown | - | -15.3 | -127.52 | - | - | Upgrade
|
| Legal Settlements | - | -0.12 | -0.21 | -0.35 | -0.14 | Upgrade
|
| Pretax Income | 41.86 | -3.79 | -186.22 | 477.23 | 1,041 | Upgrade
|
| Income Tax Expense | -7.97 | 19.04 | 4.57 | 32.37 | 105 | Upgrade
|
| Earnings From Continuing Operations | 49.83 | -22.84 | -190.79 | 444.85 | 935.57 | Upgrade
|
| Minority Interest in Earnings | 1.22 | 3.16 | 1.16 | 2.01 | -5.38 | Upgrade
|
| Net Income | 51.05 | -19.68 | -189.62 | 446.87 | 930.19 | Upgrade
|
| Net Income to Common | 51.05 | -19.68 | -189.62 | 446.87 | 930.19 | Upgrade
|
| Net Income Growth | - | - | - | -51.96% | - | Upgrade
|
| Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 10 | Upgrade
|
| Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 11 | Upgrade
|
| Shares Change (YoY) | 0.31% | -1.91% | -3.47% | -3.88% | -0.55% | Upgrade
|
| EPS (Basic) | 5.31 | -2.05 | -19.41 | 44.15 | 88.66 | Upgrade
|
| EPS (Diluted) | 5.31 | -2.05 | -19.41 | 44.15 | 88.33 | Upgrade
|
| EPS Growth | - | - | - | -50.02% | - | Upgrade
|
| Free Cash Flow | -90.78 | -39.15 | -68.86 | 326.25 | 696.97 | Upgrade
|
| Free Cash Flow Per Share | -9.44 | -4.08 | -7.05 | 32.23 | 66.19 | Upgrade
|
| Dividend Per Share | - | - | 2.500 | - | - | Upgrade
|
| Gross Margin | 33.72% | 19.40% | 17.84% | 37.30% | 64.81% | Upgrade
|
| Operating Margin | 5.07% | -15.70% | -13.77% | 26.77% | 57.05% | Upgrade
|
| Profit Margin | 8.32% | -4.19% | -34.94% | 25.84% | 50.68% | Upgrade
|
| Free Cash Flow Margin | -14.79% | -8.34% | -12.69% | 18.87% | 37.97% | Upgrade
|
| EBITDA | 54.41 | -54.02 | -50.74 | 481.34 | 1,065 | Upgrade
|
| EBITDA Margin | 8.87% | -11.51% | -9.35% | 27.84% | 58.02% | Upgrade
|
| D&A For EBITDA | 23.31 | 19.66 | 24.01 | 18.38 | 17.79 | Upgrade
|
| EBIT | 31.1 | -73.68 | -74.75 | 462.96 | 1,047 | Upgrade
|
| EBIT Margin | 5.07% | -15.70% | -13.77% | 26.77% | 57.05% | Upgrade
|
| Effective Tax Rate | - | - | - | 6.78% | 10.09% | Upgrade
|
| Revenue as Reported | 613.75 | 514.69 | 605.48 | 1,733 | 1,839 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.